True Wealth Design LLC Takes $31,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

True Wealth Design LLC purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 771 shares of the real estate investment trust’s stock, valued at approximately $31,000.

Other large investors have also modified their holdings of the company. Versant Capital Management Inc bought a new position in Omega Healthcare Investors in the 2nd quarter worth about $26,000. UMB Bank n.a. boosted its position in shares of Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 516 shares during the period. DiNuzzo Private Wealth Inc. acquired a new position in shares of Omega Healthcare Investors during the third quarter worth approximately $33,000. V Square Quantitative Management LLC grew its holdings in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 323 shares in the last quarter. Finally, Truvestments Capital LLC acquired a new stake in Omega Healthcare Investors in the 3rd quarter valued at approximately $43,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

Insider Activity

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Omega Healthcare Investors Trading Down 0.1 %

Omega Healthcare Investors stock opened at $40.61 on Monday. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42. The firm’s 50 day moving average price is $40.61 and its two-hundred day moving average price is $37.40. The firm has a market cap of $10.96 billion, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 1.26 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.60%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Wall Street Analyst Weigh In

OHI has been the subject of several recent analyst reports. BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a research note on Thursday, October 31st. Royal Bank of Canada increased their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets increased their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Finally, Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They set a “buy” rating and a $45.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.